skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:023973/0005   Pages: 7
Recorded: 02/02/2010
Attorney Dkt #:105576-0001
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 31
1
Patent #:
5460959
Issue Dt:
10/24/1995
Application #:
08070646
Filing Dt:
06/01/1993
Title:
TRANSDUCED FIBROBLASTS
2
Patent #:
5637483
Issue Dt:
06/10/1997
Application #:
08265554
Filing Dt:
06/23/1994
Title:
IRRADIATED TUMOR CELL VACCINE ENGINEERED TO EXPRESS GM-CSF
3
Patent #:
5904920
Issue Dt:
05/18/1999
Application #:
08486854
Filing Dt:
06/07/1995
Title:
REGULATION OF SYSTEMIC IMMUNE RESPONSES UTILIZING CYTOKINES AND ANTIGENS
4
Patent #:
6432700
Issue Dt:
08/13/2002
Application #:
09033556
Filing Dt:
03/02/1998
Title:
ADENOVIRUS VECTORS CONTAINING HETEROLOGOUS TRANSCRIPTION REGULATORY ELEMENTS AND METHODS OF USING SAME
5
Patent #:
6900049
Issue Dt:
05/31/2005
Application #:
09392822
Filing Dt:
09/09/1999
Publication #:
US20010053352
Pub Dt:
12/20/2001
Title:
ADENOVIRUS VECTORS CONTAINING CELL STATUS-SPECIFIC RESPONSE ELEMENTS AND METHODS OF USE THEREOF
6
Patent #:
6495130
Issue Dt:
12/17/2002
Application #:
09474699
Filing Dt:
12/29/1999
Title:
TARGET CELL-SPECIFIC ADENOVIRAL VECTORS CONTAINING E3 AND METHODS OF USE THEREOF
7
Patent #:
7217421
Issue Dt:
05/15/2007
Application #:
09610891
Filing Dt:
07/06/2000
Title:
NOVEL CANCER-ASSOCIATED ANTIGENS AND METHODS OF THEIR IDENTIFICATION AND USE
8
Patent #:
6692736
Issue Dt:
02/17/2004
Application #:
09814351
Filing Dt:
03/21/2001
Publication #:
US20030148520
Pub Dt:
08/07/2003
Title:
CELL-SPECIFIC ADENOVIRUS VECTORS COMPRISING AN INTERNAL RIBOSOME ENTRY SITE
9
Patent #:
7001764
Issue Dt:
02/21/2006
Application #:
10139089
Filing Dt:
05/02/2002
Publication #:
US20030152553
Pub Dt:
08/14/2003
Title:
COMPOSITIONS COMPRISING TISSUE SPECIFIC ADENOVIRAL VECTORS
10
Patent #:
6991935
Issue Dt:
01/31/2006
Application #:
10226820
Filing Dt:
08/21/2002
Publication #:
US20030118555
Pub Dt:
06/26/2003
Title:
TARGET CELL-SPECIFIC ADENOVIRAL VECTORS CONTAINING E3 AND METHODS OF USE THEREOF
11
Patent #:
7176022
Issue Dt:
02/13/2007
Application #:
10323664
Filing Dt:
12/20/2002
Publication #:
US20040121300
Pub Dt:
06/24/2004
Title:
DIRECTLY INJECTABLE FORMULATIONS WHICH PROVIDE ENHANCED CRYOPROTECTION OF CELL PRODUCTS
12
Patent #:
NONE
Issue Dt:
Application #:
10404662
Filing Dt:
04/02/2003
Publication #:
US20040197312
Pub Dt:
10/07/2004
Title:
Cytokine-expressing cellular vaccine combinations
13
Patent #:
7485291
Issue Dt:
02/03/2009
Application #:
10452253
Filing Dt:
06/03/2003
Publication #:
US20040265955
Pub Dt:
12/30/2004
Title:
COMPOSITIONS AND METHODS FOR GENERATING MULTIPLE POLYPEPTIDES FROM A SINGLE VECTOR USING A VIRUS DERIVED PEPTIDE CLEAVAGE SITE, AND USES THEREOF
14
Patent #:
NONE
Issue Dt:
Application #:
10807449
Filing Dt:
03/24/2004
Publication #:
US20050002916
Pub Dt:
01/06/2005
Title:
Cytokine-expressing cellular vaccine combinations
15
Patent #:
7498024
Issue Dt:
03/03/2009
Application #:
10831302
Filing Dt:
04/26/2004
Publication #:
US20050003482
Pub Dt:
01/06/2005
Title:
COMPOSITIONS AND METHODS FOR ENHANCED EXPRESSION OF IMMUNOGLOBULINS FROM A SINGLE VECTOR USING A PEPTIDE CLEAVAGE SITE
16
Patent #:
7709224
Issue Dt:
05/04/2010
Application #:
10831304
Filing Dt:
04/26/2004
Publication #:
US20050042721
Pub Dt:
02/24/2005
Title:
COMPOSITIONS AND METHODS FOR ENHANCED EXPRESSION OF RECOMBINANT POLYPEPTIDES FROM A SINGLE VECTOR USING A PEPTIDE CLEAVAGE SITE
17
Patent #:
7186699
Issue Dt:
03/06/2007
Application #:
10855559
Filing Dt:
05/28/2004
Publication #:
US20050031593
Pub Dt:
02/10/2005
Title:
METHOD FOR TREATING CANCER BY VECTOR-MEDIATED DELIVERY OF ONE OR MORE ANTI-ANGIOGENIC OR PRO-APOPTOTIC GENES
18
Patent #:
7575919
Issue Dt:
08/18/2009
Application #:
10938227
Filing Dt:
09/09/2004
Publication #:
US20050169890
Pub Dt:
08/04/2005
Title:
ADENOVIRUS VECTORS CONTAINING CELL STATUS-SPECIFIC RESPONSE ELEMENTS AND METHODS OF USE THEREOF
19
Patent #:
7714119
Issue Dt:
05/11/2010
Application #:
11179639
Filing Dt:
07/13/2005
Publication #:
US20060034805
Pub Dt:
02/16/2006
Title:
AAV VECTOR COMPOSITIONS AND METHODS FOR ENHANCED EXPRESSION OF IMMUNOGLOBULINS USING THE SAME
20
Patent #:
NONE
Issue Dt:
Application #:
11181850
Filing Dt:
07/15/2005
Publication #:
US20060292682
Pub Dt:
12/28/2006
Title:
Addition of transgenes into adenoviral vectors
21
Patent #:
NONE
Issue Dt:
Application #:
11206135
Filing Dt:
08/18/2005
Publication #:
US20060188479
Pub Dt:
08/24/2006
Title:
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
22
Patent #:
7226606
Issue Dt:
06/05/2007
Application #:
11274856
Filing Dt:
11/16/2005
Publication #:
US20060078544
Pub Dt:
04/13/2006
Title:
NOVEL CANCER-ASSOCIATED ANTIGENS AND METHODS OF THEIR IDENTIFICATION AND USE
23
Patent #:
NONE
Issue Dt:
Application #:
11484954
Filing Dt:
07/12/2006
Publication #:
US20060251683
Pub Dt:
11/09/2006
Title:
Directly injectable formulations which provide enhanced cryoprotection of cell products
24
Patent #:
7632509
Issue Dt:
12/15/2009
Application #:
11488568
Filing Dt:
07/18/2006
Publication #:
US20070059820
Pub Dt:
03/15/2007
Title:
METHODS TO EXPRESS RECOMBINANT PROTEINS FROM LENTIVIRAL VECTORS
25
Patent #:
7919079
Issue Dt:
04/05/2011
Application #:
11729339
Filing Dt:
03/28/2007
Publication #:
US20080014222
Pub Dt:
01/17/2008
Title:
CANCER IMMUNOTHERAPY COMPOSITIONS AND METHODS OF USE
26
Patent #:
7645587
Issue Dt:
01/12/2010
Application #:
11799584
Filing Dt:
05/02/2007
Publication #:
US20070212739
Pub Dt:
09/13/2007
Title:
NOVEL CANCER-ASSOCIATED ANTIGENS AND METHODS OF THEIR IDENTIFICATION AND USE
27
Patent #:
7968333
Issue Dt:
06/28/2011
Application #:
11894776
Filing Dt:
08/20/2007
Publication #:
US20090130061
Pub Dt:
05/21/2009
Title:
ADENOVIRUS VECTORS CONTAINING CELL STATUS-SPECIFIC RESPONSE ELEMENTS AND METHODS OF USE THEREOF
28
Patent #:
7662623
Issue Dt:
02/16/2010
Application #:
11977787
Filing Dt:
10/26/2007
Publication #:
US20080280356
Pub Dt:
11/13/2008
Title:
COMPOSITIONS AND METHODS FOR ENHANCED EXPRESSION OF RECOMBINANT POLYPEPTIDES FROM A SINGLE VECTOR USING A PEPTIDE CLEAVAGE SITE
29
Patent #:
NONE
Issue Dt:
Application #:
11977788
Filing Dt:
10/26/2007
Publication #:
US20100317096
Pub Dt:
12/16/2010
Title:
Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
30
Patent #:
NONE
Issue Dt:
Application #:
12220686
Filing Dt:
07/24/2008
Publication #:
US20090270485
Pub Dt:
10/29/2009
Title:
Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
31
Patent #:
RE42373
Issue Dt:
05/17/2011
Application #:
12221052
Filing Dt:
07/29/2008
Title:
ADENOVIRUS VECTORS CONTAINING CELL STATUS-SPECIFIC RESPONSE ELEMENTS AND METHODS OF USE THEREOF
Assignor
1
CELL GENESYS, INC.
Exec Dt:
10/14/2009
Assignee
1
BIOSANTE PHARMACEUTICALS, INC.
111 BARCLAY BOULEVARD
LINCOLNSHIRE, ILLINOIS 60069
Correspondence name and address
ROPES & GRAY LLP
1211 AVENUE OF THE AMERICAS
NEW YORK, NEW YORK 10036

Search Results as of: 06/18/2024 03:49 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT